Xerostomia, salivary characteristics and gland volumes following intensity-modulated radiotherapy for nasopharyngeal carcinoma: a two-year follow up

by Lim, C., Manton, D.J, Pang, E.P.P, Reynolds, E.C, Sim, C.P.C, Soong, Y.L, Walker, G.D, Wee, J.T.S
Published 2018

MFSD4A inhibits the malignant progression of nasopharyngeal carcinoma by targeting EPHA2

by Gan, C., Jiang, W., Kong, X., Luo, Z., Qin, G., Yang, H., Zhang, R.
Published 2022

Plasma Epstein-Barr Virus MicroRNA BART8-3p as a Diagnostic and Prognostic Biomarker in Nasopharyngeal Carcinoma

by Guo, Q., Lin, C., Lin, K., Lin, S., Lu, T., Pan, J., Su, Y., Xu, Y., Zhang, B., Zong, J.
Published 2022

A polygenic risk score for nasopharyngeal carcinoma shows potential for risk stratification and personalized screening

by Adami, H.-O, Bei, J., Cai, Y., Cao, L., Cao, S., Chang, E.T, Deng, B., Deng, C., Dong, S., Fan, P., Feng, L., Feng, Y., He, Y.-Q, Hu, Y., Hu, Z., Huang, G., Ji, M., Jia, W.-H, Jia, Y., Jin, G., Kozlakidis, Z., Lam, T.-H, Li, D., Li, F., Li, X., Liang, X., Liao, Y., Liu, J., Liu, Q., Lung, M.L, Luo, L., Ma, J., Mai, H., Mai, Z.-M, Qin, W., Shen, H., Song, J., Sun, Y., Tang, M., Tong, X., Wang, R., Wang, T.-M, Wu, B., Wu, Y., Wu, Z., Xiao, R., Xie, S.-H, Xu, M., Xue, W., Yang, D., Ye, W., Yuan, L., Zeng, Y.-X, Zhan, J., Zhang, J., Zhang, P., Zhang, S., Zhang, W., Zhang, Z., Zheng, M., Zheng, X., Zheng, Y., Zhou, T., Zhou, Y.
Published 2022

Nasopharyngeal carcinoma (NPC) risk factors: A systematic review and meta-analysis of the association with lifestyle, diets, socioeconomic and sociodemographic in asian region

by Azmi, N.S.A, Kaur, G., Mangantig, E., Musa, Y., Mydin, R.B.S.M.N, Okekpa, S.I, Zahari, S.N.S
Published 2019

CD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinoma

by Abdul Aziz, N., Abdul Razak, F.R, Ahmad, M., Chin, Y.M, Chu, T.L, Hoe, S.L.L, Khoo, A.S.-B, Koay, C.E, Liew, K., Lo, K.-W, Mohamed Shahrehan, N.A, Mohd Kornain, N.K, Ng, C.-C, Peh, S.-C, Tan, L.P, Teow, S.-Y
Published 2017

Administration of oral maintenance chemotherapy for 1 year following definitive chemoradiotherapy may improve the survival of patients with stage N3 nasopharyngeal carcinoma

by Chen, B., Guo, Q., Hu, C., Liang, Q., Lin, S., Liu, Y., Pan, J., Xu, H., Xu, Y., Zong, J.
Published 2021

Benefit of chemotherapy in stage III nasopharyngeal carcinoma: Analysis of the surveillance, epidemiology, and end results database

by Hu, D.-F, Li, M.-Y, Li, W.-Z, Shen, E.-D, Xiang, Y.-Q, Xiang, Z.-F, Xiong, H.-C, Zhang, Z.-C
Published 2021

Efficacy and safety of apatinib in recurrent/metastatic nasopharyngeal carcinoma: A pilot study

by Bai, Y., Chua, K.L.M, Chua, M.L.K, Fan, C., Huang, L., Lim, D.W.T, Long, B., Shu, X., Tan, S.H, Wang, Y., Wee, J.T.S, Wu, Y., Xie, Y., Zhang, X.
Published 2021

CPT1A-mediated fatty acid oxidation promotes cell proliferation via nucleoside metabolism in nasopharyngeal carcinoma

by Bode, A.M, Cao, Y., Dong, X., Du, Q., Fan, J., Gao, Q., Hu, J., Li, W., Li, Y., Liao, W., Liu, N., Luo, X., Shi, F., Tan, Z., Tang, M., Weng, X., Wu, W., Xiao, L., Xie, L., Yang, L., Zhang, X., Zhao, L., Zhou, J.
Published 2022